Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Europees platform voor delen van data over neurodegeneratieve ziekten
sep 2021 | Bewegingsstoornissen, Dementie